The Boston Business Journal Profiles Michelle Basil on Life Science Financing and Deal-MakingPrint PDF
Michelle L. Basil, chair of Nutter’s Life Sciences practice group and a partner in the firm’s Business Department, was featured on life science financing and deal-making in the Boston Business Journal. In the article, “Nutter, Halloran to hold panel on life science financing and deal-making Thursday,” Michelle discusses corporate venture funding and how she is seeing a greater willingness to work with big pharma firms than in the past. She points out that large drug makers are motivated by a need for new drugs to fill out their pipelines. However, for small biotechs, partnerships with big pharma offer not only equity investment, but often come with access to their large research and development organizations. Michelle is moderating Nutter and Halloran Consulting’s Life Sciences Executive Panel “Let's Make a Deal: A Look Behind the Curtain in Life Sciences Strategic Funding Transactions” on June 16.